he usefulness of atrial screw-in leads has already been established. 1 However, pacing threshold rise is occasionally observed, particularly in the acute phase after implantation. 2 Steroid-eluting screw-in leads were developed in order to overcome this problem by suppressing the acute inflammatory process. 3 However, the number of implants of steroid-eluting screw-in leads, especially with atrial free wall pacing, is still limited. The purpose of this study was to clarify the acute performance of atrial steroid-eluting screw-in leads in comparison with that of nonsteroid screw-in leads.
The aim of this study was to clarify the acute performance of steroid-eluting screw-in leads in comparison with that of nonsteroid screw-in leads for atrial free wall pacing. In 114 cases (68 males, 46 females, average age 70 years) with atrial free wall pacing by screw-in leads, pacing thresholds and P-wave amplitudes were compared at the time of implantation and 1 week later between 68 cases of nonsteroid and 46 cases of steroid-eluting screwin leads. No significant differences were seen between the 2 groups at implantation in either voltage or current thresholds measured at pulse widths of 0.1, 0.3, 0.6, 1.0, 2.0 ms, or P-wave amplitudes. Pulse width thresholds at outputs of 2.5 V and 5.0 V were significantly lower for steroid leads 1 week after implantation (2.5 V: 0.34±0.27 ms nonsteroid vs 0.12±0.08 ms steroid, p<0.001; 5.0 V: 0.12±0.08 ms nonsteroid vs 0.06±0.02 ms steroid, p<0.01). P-wave amplitudes after 1 week were significantly higher for steroid leads (2.6±0.7 mV nonsteroid vs 3.0±1.2 mV steroid, p<0.001). Threshold rise, including pacing failure, was observed in 15 (22%) of the nonsteroid leads, but in only 1 (2%) of the steroid leads. In conclusion, steroid-eluting screw-in leads suppress the acute rise of pacing thresholds in the right atrial free wall and their acute performance is better than that of nonsteroid leads. These results suggest that appropriate low-output atrial pacing is feasible immediately after implantation. ( were also measured. One week after implantation, pulse width thresholds measured at outputs of 2.5 V and 5.0 V and P-wave amplitude were compared between the steroidlead and nonsteroid-lead groups. All parameters at operation were measured by a pacing system analyzer (CPI No. 2200). In all patients, the initial output setting was between 3.5 and 5.0 V with a pulse width of 0.6 ms. Pacing status after implantation was observed and classified as follows: (i) pacing failure, defined as when the pulse width threshold increased to more than 0.6 ms with the output of 5.0 V; and (ii) threshold rise, defined as when the pulse width threshold increased to more than 0.5 ms at an output of 2.5 V.
Results

Threshold Measurement at Implantation
Voltage and current thresholds, P-wave amplitudes, and pacing impedances in both groups are shown in Table 1 . Voltage and current strength-duration curves were constructed using those data (Fig 1) . No significant differences were recognized between the 2 groups, although pacing impedances trended lower in the steroid-lead group.
Threshold Measurements 1 Week After Implantation
Pulse width thresholds were significantly lower in steroid-eluting leads (Fig 2) . They averaged 0.34±0.27 ms in nonsteroid leads and 0.12±0.08 ms in steroid-eluting leads at an output of 2.5 V (p<0.001). When measured at an output of 5.0 V, they averaged 0.12±0.18 ms in nonsteroidleads and 0.06±0.02 ms in steroid-eluting leads (p<0.01).
Threshold rises were observed in 15 of 69 (22%) patients with nonsteroid-leads; in 1 case pacing failure occurred. However, only 1 case of threshold rise was recognized in the steroid-eluting leads (Table 2 ). However, in no case was re-operation necessary as we could manage the patients with threshold rises by reprogramming the output voltage or pulse width. P-wave amplitudes were 2.6±0.7 mV in nonsteroid-leads and 3.0±1.2 mV in steroidleads (p<0.001). In addition, they significantly decreased in the nonsteroid-leads 1 week after implantation, but did not decrease in the steroid-eluting leads (Fig 3) .
Discussion
The reliability of atrial pacing largely depends on the lead placement stability. In the early stages of pacing research, the right atrium could not be used for pacing due to the difficulty of fixation. Later, right atrial appendage pacing with a J-shaped lead was developed; however, it has also had a disadvantage in that the right atrial appendage was the only site of fixation regardless of whether the pacing and sensing thresholds were suitable or not. In addition, dislodgment was a major concern. However, the development of active fixation leads solved these problems, and their long-term reliability has been confirmed. 1, 2, 4 We have emphasized that the screw-in lead enables the lead to be repeatedly repositioned anywhere to get the proper thresholds and amplitude without any concerns about dislodgment, 1 which is why we prefer to use a screw-in lead and select the right atrial free wall as the fixation site. However, the occasional problem of acute threshold rise has remained. Steroid-eluting screw-in leads were developed for the prevention of acute threshold rise by suppressing the acute inflammatory process. There have been several reports that tined J-shaped steroid-eluting leads had favorable effects for atrial pacing. 5, 6 Although a few studies of nonsteroid screw-in leads attached to the atrial free wall have been reported, 1,7 data are still more scarce regarding steroid-eluting screw-in leads.
In the present study, we clarified the favorable acute performance of steroid-eluting screw-in leads fixed to the right atrial free wall. At implantation, the voltage and current thresholds, and P-wave amplitudes were comparable to those of nonsteroid screw-in leads. No significant difference was noted in pacing impedance between steroideluting and nonsteroid leads.
After 1 week, pulse width thresholds measured at 2.5 and 5.0 V were significantly lower in the steroid leads. The average value at 2.5 V was 0.12 ms. In contrast, it was 0.34 ms in the nonsteroid leads. As well, pacing failure was observed in 3 cases despite the relatively high output setting (5.0 V, 0.6 ms). Threshold rises to more than 0.5 ms at 2.5 V were detected in 12 cases with nonsteroid-leads, but in only 1 case with steroid-eluting leads. P-wave amplitudes significantly decreased in nonsteroid-leads after 1 week, but did not change in steroid-eluting leads.
These results indicate that the steroid-eluting screw-in lead has a favorable pacing and sensing performance during the acute phase of atrial pacing. An appropriate lowenergy setting is feasible in steroid-eluting leads from the time of implantation onwards. In addition, steroid-eluting leads might also be useful for suppression of drug-induced threshold rise, which is sometimes observed with class Ic antiarrhythmic drugs. 8 Although the present study described only the acute performance, several investigators have confirmed the long-term reliability of steroid-eluting leads, so good chronic performance can also be expected. Crossley et al reported the improvement of subacute and chronic stimulation thresholds, 9 and therefore it should be possible to extend pulse generator longevity.
In conclusion, steroid-eluting screw-in leads suppress the acute rise of pacing thresholds in the right atrial free wall and their acute performance is better than that of nonsteroid screw-in leads. These results suggest that appropriate low-output atrial pacing is feasible immediately after implantation.
